Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 10.57% | 69.23 | 0.0% | $1059.52m | |
| NVAX | Novavax, Inc. | 9.16% | 103.00 | 251.8% | $834.51m | |
| AMGN | Amgen, Inc. | 1.21% | 252.06 | 1.3% | $702.20m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.92% | 626.59 | 2.5% | $669.14m | |
| GILD | Gilead Sciences, Inc. | 1.26% | 77.28 | 1.0% | $638.74m | |
| BIIB | Biogen, Inc. | 0.64% | 280.67 | 1.6% | $605.43m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.20% | 295.05 | 1.9% | $476.49m | |
| VXRT | Vaxart, Inc. | 29.57% | 10.34 | 0.0% | $371.75m | |
| ILMN | Illumina, Inc. | 1.61% | 376.22 | 3.5% | $306.04m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.63% | 109.50 | 2.0% | $218.54m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.69% | 128.19 | 4.3% | $210.30m | |
| SGEN | Seattle Genetics, Inc. | 0.56% | 175.32 | 6.1% | $193.46m | |
| SRNE | Sorrento Therapeutics, Inc. | -1.30% | 7.96 | 1.8% | $190.46m | |
| IMMU | Immunomedics, Inc. | 1.79% | 42.06 | 11.0% | $180.17m | |
| BNTX | BioNTech SE | 13.66% | 79.97 | 0.0% | $177.93m |
Company Profile
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.